Yadong Yuan

5.2k total citations · 1 hit paper
51 papers, 3.1k citations indexed

About

Yadong Yuan is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Internal Medicine. According to data from OpenAlex, Yadong Yuan has authored 51 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 8 papers in Internal Medicine. Recurrent topics in Yadong Yuan's work include Pulmonary Hypertension Research and Treatments (9 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers) and Venous Thromboembolism Diagnosis and Management (8 papers). Yadong Yuan is often cited by papers focused on Pulmonary Hypertension Research and Treatments (9 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers) and Venous Thromboembolism Diagnosis and Management (8 papers). Yadong Yuan collaborates with scholars based in China, Switzerland and United States. Yadong Yuan's co-authors include Yibin Yang, Jinjin Zhang, Youqin Yan, Yiyuan Cao, Yadong Gao, Cezmi A. Akdiş, Xiang Dong, Zheng Duan, Xue Han and Shuxia Song and has published in prestigious journals such as PLoS ONE, Scientific Reports and Energy.

In The Last Decade

Yadong Yuan

43 papers receiving 3.0k citations

Hit Papers

Clinical characteristics of 140 patients infected with SA... 2020 2026 2022 2024 2020 500 1000 1.5k 2.0k 2.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yadong Yuan China 11 2.2k 1.1k 510 365 293 51 3.1k
Qinyong Hu China 14 1.6k 0.7× 844 0.7× 502 1.0× 279 0.8× 182 0.6× 35 2.5k
Hongliu Cai China 16 1.6k 0.7× 774 0.7× 416 0.8× 202 0.6× 257 0.9× 51 2.7k
Yiyuan Cao China 11 3.2k 1.5× 1.6k 1.4× 761 1.5× 458 1.3× 426 1.5× 22 4.3k
Shuoqi Zhang China 8 3.4k 1.5× 1.9k 1.7× 603 1.2× 252 0.7× 201 0.7× 10 4.2k
Xiang Dong China 12 3.4k 1.5× 1.7k 1.5× 797 1.6× 437 1.2× 469 1.6× 29 4.6k
Yingzhen Du China 12 1.5k 0.7× 816 0.7× 354 0.7× 241 0.7× 148 0.5× 25 2.3k
Ziwei Hu China 9 3.4k 1.5× 1.9k 1.7× 604 1.2× 258 0.7× 202 0.7× 22 4.3k
Ian Huang Indonesia 25 2.2k 1.0× 1.2k 1.1× 717 1.4× 149 0.4× 225 0.8× 47 3.3k

Countries citing papers authored by Yadong Yuan

Since Specialization
Citations

This map shows the geographic impact of Yadong Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yadong Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yadong Yuan more than expected).

Fields of papers citing papers by Yadong Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yadong Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yadong Yuan. The network helps show where Yadong Yuan may publish in the future.

Co-authorship network of co-authors of Yadong Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Yadong Yuan. A scholar is included among the top collaborators of Yadong Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yadong Yuan. Yadong Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Xiong, Shuping, et al.. (2024). Which is the safer option for adult patients between peripherally inserted central catheters and midline catheters: a meta-analysis. Infection Control and Hospital Epidemiology. 46(1). 27–34. 1 indexed citations
5.
Liu, Xia, Xiaojing Jiao, Yang Li, et al.. (2023). Prevalence, Risk Factor and Clinical Characteristics of Venous Thrombus Embolism in Patients with Acute Exacerbation of COPD: A Prospective Multicenter Study. International Journal of COPD. Volume 18. 907–917. 11 indexed citations
7.
Xu, Xiaolong, Yadong Yuan, Rongmeng Jiang, et al.. (2022). Effectiveness of Lianhua Qingwen Capsule in Treatment of Asymptomatic COVID-19 Patients: A Randomized, Controlled Multicenter Trial. Journal of Integrative and Complementary Medicine. 28(11). 887–894. 9 indexed citations
8.
Guo, Hong, et al.. (2021). Comparison of invasive intubation and noninvasive mechanical ventilation in patients with chronic obstructive pulmonary disease and obstructive sleep apnoea syndrome. Journal of International Medical Research. 49(12). 3619129240–3619129240. 2 indexed citations
9.
Yuan, Yadong, et al.. (2021). Association of smoking and cardiovascular disease with disease progression in COVID-19: a systematic review and meta-analysis. Epidemiology and Infection. 149. 1–26. 7 indexed citations
10.
Yuan, Yadong, et al.. (2021). Efficacy and Safety of Lianhuaqingwen Capsules for the Prevention of Coronavirus Disease 2019: A Prospective Open-Label Controlled Trial. Evidence-based Complementary and Alternative Medicine. 2021. 1–9. 8 indexed citations
11.
Zhang, Jinjin, Xiang Dong, Yiyuan Cao, et al.. (2020). Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy. 75(7). 1730–1741. 2687 indexed citations breakdown →
12.
Wei, Tianchao, Yadong Yuan, Yuanqin Zhang, et al.. (2018). Molecular characterization of two novel sub-sublineages of pigeon paramyxovirus type 1 in China. Archives of Virology. 163(11). 2971–2984. 11 indexed citations
13.
Zhao, Jing, et al.. (2017). Risk factors associated with acute exacerbation of chronic obstructive pulmonary disease: A retrospective analysis in 4624 patients. Biomedical Research-tokyo. 28(9). 3855–3859. 3 indexed citations
14.
Lü, Yang, et al.. (2017). N-acetyl-l-cysteine ameliorates the PM2.5-induced oxidative stress by regulating SIRT-1 in rats. Environmental Toxicology and Pharmacology. 57. 70–75. 23 indexed citations
15.
Su, Nan, Jiangtao Lin, Jing Li, et al.. (2014). Evaluation of asthma control: a questionnaire-based survey in China. Chinese Medical Journal. 127(11). 2030–2036. 4 indexed citations
16.
Yuan, Yadong, et al.. (2013). [Altered expressions of alkane monooxygenase and hypoxia inducible factor-1α expression in lung tissue of rat hypoxic pulmonary hypertension].. PubMed. 93(40). 3226–9. 1 indexed citations
17.
Su, Nan, Jiangtao Lin, Ping Chen, et al.. (2013). Evaluation of asthma control and patient’s perception of asthma: findings and analysis of a nationwide questionnaire-based survey in China. Journal of Asthma. 50(8). 861–870. 30 indexed citations
18.
Zhang, Yanping, Wen‐Bin Li, Weili Wang, et al.. (2012). siRNA against plasminogen activator inhibitor-1 ameliorates bleomycin-induced lung fibrosis in rats. Acta Pharmacologica Sinica. 33(7). 897–908. 41 indexed citations
19.
Zhang, Yanping, Weili Wang, Jian Liu, et al.. (2012). Plasminogen activator inhibitor-1 promotes the proliferation and inhibits the apoptosis of pulmonary fibroblasts by Ca2+ signaling. Thrombosis Research. 131(1). 64–71. 32 indexed citations
20.
Wang, Xiaohong, et al.. (2003). [Clinical observation on effect of auricular acupoint pressing in treating sleep apnea syndrome].. PubMed. 23(10). 747–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026